🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.660
0.00 (0.00%)
At close: Nov 20, 2026, 4:00 PM EST
2.650
-0.010 (-0.38%)
After-hours: Nov 20, 2026, 7:55 PM EST

Aytu BioPharma Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-20.1-14.25-13.56-15.84-17.05-108.78
Depreciation & Amortization
4.253.935.386.737.710.15
Other Amortization
0.110.110.110.60.56-
Asset Writedown & Restructuring Costs
--8.26-2.7375.46
Stock-Based Compensation
0.750.690.582.375.725.25
Other Operating Activities
10.566.972.786.06-5.17-0.03
Change in Accounts Receivable
12.898.38-7.635.2-7.246.53
Change in Inventory
1.812.390.38-4.82-3.491.3
Change in Accounts Payable
-3.84-2.320.29-2.083.09-7.68
Change in Other Net Operating Assets
-2.81-2.610.96-5.032.65-11.01
Operating Cash Flow
3.623.28-1.94-1.39-5.13-28.82
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-0.03-0.03-0.23-0.33--
Sale of Property, Plant & Equipment
--0.67---
Cash Acquisitions
------3.18
Sale (Purchase) of Intangibles
---3---
Other Investing Activities
-----0.12-0.07
Investing Cash Flow
-0.03-0.03-2.56-0.33-0.12-3.25

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
--6.670.83--
Long-Term Debt Issued
--1.8613-15
Total Debt Issued
-5.81-8.5313.83-15
Short-Term Debt Repaid
--2.99---2.25-4.12
Long-Term Debt Repaid
--1.86-1.86-15.72-0.1-16.1
Total Debt Repaid
-4.92-4.85-1.86-15.72-2.35-20.22
Net Debt Issued (Repaid)
-10.73-4.856.67-1.89-2.35-5.22
Issuance of Common Stock
--14.843.4715.5811.69
Other Financing Activities
--3.05-6.07-2.84-4.36-4.94
Financing Cash Flow
-10.73-7.915.44-1.268.871.53

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash Flow
-7.14-4.6410.95-2.983.63-30.54

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
3.63.25-2.17-1.72-5.13-28.82
Free Cash Flow Growth
------
Free Cash Flow Margin
6.14%5.65%-3.26%-2.63%-6.95%-29.82%
Free Cash Flow Per Share
0.240.26-0.34-0.31-1.54-19.61
Levered Free Cash Flow
10.415.6-9.493.925.56-17.72
Unlevered Free Cash Flow
11.426.67-7.296.498.22-17.71

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
1.791.792.824.043.813.15
Cash Income Tax Paid
0.210.211.421.61--
Change in Working Capital
8.065.83-6-6.73-4.99-10.86
SEC Filings: 10-K · 10-Q